• Accelerating TB vaccine Research & Development through partnership
    • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Access to services
      • MTBVAC in Newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • MTBVACN3
        • Work packages
        • Governance
        • The consortium and its partners
        • Publications and news
        • Acknowledgement
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Operational Office

    Home / About us / Organisation / Operational Office
    • Dr Nick Drager
      Dr Nick DragerExecutive Director
    • Cora Agterdenbosch
      Cora AgterdenboschSr. Management Assistent
    • Koen de Lange
      Koen de LangeGeneral Legal Counsel
    • Anne Meinema MSc
      Anne Meinema MScDirector Finance and Administration
    • Marit Holleman MSc
      Marit Holleman MScSr. Knowledge exchange and networking manager & Project Manager
    • Dr Gerald Voss
      Dr Gerald VossOperational Office Scientific Director
    • Dr Robert Golinski
      Dr Robert GolinskiSr. Project Officer
    • Dr Elly van Riet
      Dr Elly van RietSr. Scientist
      Menu
      • Home
      • About us
      • What we do
      • How we work
      • For researchers and vaccine developers
      • For funders
      • Pipeline of vaccines
      • News
      TuBerculosis Vaccine Initiative (TBVI)

      Runderweg 6
      8219 PK Lelystad
      The Netherlands
      Email: info@tbvi.eu
      Phone: +31 320 277 550

      © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

      Start typing and press Enter to search

      Cookies

      This website uses cookies that help the website function

      OK No